Jere Mammino, DO, Advanced Dermatology, Orlando, Florida; Karan Lal, BS, New York College of Osteopathic Medicine, PO Box 8000 Northern Blvd, Old Westbury, NY Disclosure: The authors report no relevant conflicts
by Jeffrey Messenger, MD; Shane Clark, MD; Susan Massick, MD; Mark Bechtel, MD College of Medicine, The Ohio State University, Columbus, Ohio; Division of Dermatology, The Ohio State University, Columbus,
Michael Kassardjian, DO, Western University of Health Sciences/Pacific Hospital of Long Beach Department of Dermatology, Long Beach, California; Julie Frederickson, DO, O’Bleness Memorial Hospital/Ohio University Heritage College of Osteopathic Medicine,
Shannon C. Trotter, DO, The Ohio State University Wexner Medical Center, Division of Dermatology, Columbus, Ohio; Novie Sroa, MD, The Ohio State University Wexner Medical Center, Division of Dermatology, Columbus,
Emil A. Tanghetti, MD Center for Dermatology and Laser Surgery, Sacramento, California Disclosure: Dr. Tanghetti is a consultant and speaker for Allergan, Galderma, Cynosure, and Palomar.
Jason Emer, MD, Mount Sinai School of Medicine, Departments of Dermatology and Pathology, New York, New York; Daniel Roberts, BS, Stanford School of Medicine, Department of Pathology, Stanford, California; Harleen
Helen M. Torok, MD, Trillium Creek Dermatology, Medina, Ohio Disclosure: Dr. Torok was an investigator in the Medicis-sponsored Solodyn Phase 2 and 3 studies. Medicis, a division of Valeant Pharmaceuticals,
William Kirby, DO, FAOCD, Dr. Tattoff, Inc., Beverly Hills, California; Cynthia L. Chen, DO, McLaren Oakland, Pontiac, Michigan; Alpesh Desai, DO, FAOCD, Dr. Tattoff, Inc., Dallas, Texas; Tejas Desai, DO,
Philip R. Cohen, MD The University of Houston Health Center, University of Houston, Houston, Texas; The Division of Dermatology, University of California San Diego, San Diego, California; The Department of
Sonal Choudhary, MD; Michael McLeod, MS; Daniele Torchia, MD; Paolo Romanelli, MD Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida Disclosure: The authors
Philip R. Cohen, MD; Jaime A. Tschen, MD; Ronald P. Rapini, MD
Philip R. Cohen, MD; Agop Y. Bedikian, MD; Kevin B. Kim, MD
Shannon M. Campbell, DO, FAOCD; Richard R. Winkelmann, MS-III; Dawn L. Sammons, DO, FAOCD
Uzma Farooq, MD; Sonal Choudhary, MD; Michael P. McLeod, MS; Daniele Torchia, MD; Paolo Romanelli, MD
Andrew Styperek, MD, MBA, Department of Dermatology, University of Miami, Miami, Florida; Stephanie Bayers, BSBA, Department of Medicine, University of Miami, Miami, Florida; Michael Beer; Kenneth Beer, MD, FAAD, Department
Shane Clark, MD, Department of Internal Medicine, Division of Dermatology, The Ohio State University Medical Center, Columbus, Ohio; Adam Young, BS, The Ohio State University College of Medicine, Columbus, Ohio;
Ryan Goerig, MD; Chad Vogeler, BS; Matthew Keller, MD Thomas Jefferson University Hospital, Department of Dermatology and Cutaneous Biology, Philadelphia, Pennsylvania Disclosure: The authors report no relevant conflicts of interest.
Sonal Choudhary, MD; Michael McLeod, MS; Daniele Torchia, MD; Paolo Romanelli, MD Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida
Randy Tang, RN, BSN, BSE, MD, UMDNJ—Robert Wood Johnson Medical School, Camden, New Jersey; Christian R. Millett, MD, Dermatology Center, Bethesda, Maryland;; cJustin J. Green, MD, Cooper University Hospital, Camden,
Grace K. Kim, DO, Dermatology Resident (PGY-4), Valley Hospital Medical Center, Las Vegas, Nevada; James Del Rosso, DO, FAOCD, Dermatology Residency Program Director,Valley Hospital Medical Center, Las Vegas, Nevada; Adjunct